NH HB656 | 2019 | Regular Session

Status

Spectrum: Bipartisan Bill
Status: Introduced on January 16 2019 - 25% progression
Action: 2019-02-13 - Executive Session: 02/21/2019 02:00 pm Legislative Office Building 302
Pending: House Commerce and Consumer Affairs Committee
Hearing: Feb 19 @ 10:00 am in Legislative Office Building 302
Text: Latest bill text (Introduced) [HTML]

Summary

Establishing a commission to study the impact of financial initiatives for commercially insured members by drug manufacturers on prescription drug prices and health insurance premiums.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Establishing a commission to study the impact of financial initiatives for commercially insured members by drug manufacturers on prescription drug prices and health insurance premiums.

Sponsors


History

DateChamberAction
2019-02-13HouseExecutive Session: 02/21/2019 02:00 pm Legislative Office Building 302
2019-02-13HouseSubcommittee Work Session: 02/21/2019 10:30 am Legislative Office Building 302
2019-02-06HousePublic Hearing: 02/19/2019 10:00 am Legislative Office Building 302
2019-01-16HouseIntroduced 01/03/2019 and referred to Commerce and Consumer Affairs

New Hampshire State Sources


Bill Comments

feedback